We used complexes between a fourth generation polyamidoamine (PAMAM) dendrimer and one of two heterocyclic compounds — 1-(6-hydroxyhexyl)-3-(5-phenyl-isoxazole-3-yl)-urea or 5-phenyl-isoxazole-3-carboxylic acid — to reduce oxygen consumption in transverse slices of the hippocampus taken from 4-week old male rats. In vitro electrophysiological experiments revealed that the inhibitory effect of the hypoxic state on the evoked responses was enhanced in the presence of the complexes. The data were analyzed in terms of the potential antitumor effects of these complexes.
Institute of Physiology, National Academy of Sciences of Belarus, Minsk, Belarus
Bibliografia
1. Moen, I. and Stuhr, L.E.B. Hyperbaric oxygen therapy and cancer – a review. Target Oncol. 7 (2012) 233–242.
2. Depret, J., Teboul, J.L., Benoit, G., Mercat, A. and Richard, C. Global energetic failure in brain-dead patients. Transplantation 60 (1995) 966–971.
3. Pastorekova, S., Zatovicova, M. and Pastorek, J. Cancer-associated carbonic anhydrases and their inhibition. Curr. Pharm. Design 14 (2008) 685–698.
4. Kulchitsky, V.A., Talabaev, M.V., Chernov, A.N., Grigoriev, D.G., Demidchik, Y.E., Shcharbin, D.G., Chekan, N.M., Kazbanov, V.V., Gurinovich, T.A., Gordienko, A.I., Sergeeva, E.K., Potkin, V.I. and Kalunov, V.N. Improving the efficiency of chemotherapeutic drugs by the action on neuroepithelial tumors. In.: Glioma – Exploring Its Biology and Practical Relevance (Anirban Ghosh, Ed.) 21 (2011) 465–486.
5. Kamal, A., Bharathi, E.V., Reddy, J.S., Ramaiah, M.J., Dastagiri, D., Reddy, K., Viswanath, A., Reddy, T.L., Shaik, T.B., Pushpavalli, S.N. and Bhadra, M.P. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents. Eur. J. Med. Chem. 46 (2011) 691–703.
6. Cai, X., Hu, J., Xiao, J. and Cheng, Y. Dendrimer and cancer: a patent review (2006-present). Expert Opin. Ther. Pat. 23 (2013) 515–529.
7. Shcharbin, D., Dzmitruk, V., Shakhbazau, A., Goncharova, N., Seviaryn, I., Kosmacheva, S., Potapnev, M., Pedziwiatr-Werbicka, E., Bryszewska, M., Talabaev, M., Chernov, A., Kulchitsky, V., Caminade, A.-M. and Majoral, J.-P. Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carriers. Pharmaceutics 3 (2011) 458–473.
8. Ziemba, B., Matuszko, G., Bryszewska, M. and Klajnert, B. Influence of dendrimers on red blood cells. Cell. Mol. Biol. Lett. 17 (2012) 21–35.
9. Lazniewska, J., Milowska, K., Katir, N., El Kadib, A., Bryszewska M., Majoral, J.-P. and Gabryelak, T. Viologen-phosphorus dendrimers exhibit minor toxicity against a murine neuroblastoma cell line. Cell. Mol. Biol. Lett. 18 (2013) 459–478.
10. Kulchitsky, V.A., Potkin, V.I., Zubenko, Yu.S., Chernov, A.N., Talabaev, M.V., Demidchik, Y.E., Petkevich, S.K., Kazbanov, V.V., Gurinovich, T.A., Roeva, M.O., Grigoriev, D.G., Kletskov, A.V. and Kalunov, V.N. Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors. Med. Chem. 8 (2012) 22–32.
11. Garkun, Y.S., Yakubovich, N.V., Denisov, A.A., Molchanov, P.G., Emel'janova, A.A., Pashkevich, S.G. and Kulchitsky, V.A. Generation of excitatory postsynaptic potentials in the hippocampus after functional modification of glycosaminoglycans. Bull. Exp. Biol. Med. 145 (2008) 395–397.
12. Tabata, Y. Nanomaterials of drug delivery systems for tissue regeneration. Meth. Mol. Biol. 300 (2005) 81–100.